Limited-stage diffuse large B-cell lymphoma: current management and challenges by Zhang, X-Y, Collins, GP, Eyre, TA

Single arm NCRI phase II study of CHOP in combination with Ofatumumab in induction and maintenance for patients with newly diagnosed Richter’s syndrome by Eyre, TA, Clifford, R, Roberts, C, Boyle, L, Francis, A, Schuh, A, Dutton, S

Impact of intended and relative dose intensity of R‐CHOP in a large, consecutive cohort of elderly diffuse large B‐cell lymphoma patients treated with curative intent: no differenc... by Eyre, TA, Martinez-Calle, N, Hildyard, C, Eyre, DW, Plaschkes, H, Griffith, J, Wolf, J, Fields, P, Gunawan, A, Oliver, R, Djebbari, F, Booth, S, McMillan, A, Fox, CP, Bishton, MJ, Collins, GP, Hatton, CSR

Impact of intended and relative dose intensity of R‐CHOP in a large, consecutive cohort of elderly diffuse large B‐cell lymphoma patients treated with curative intent: no differenc... by Eyre, TA, Martinez-Calle, N, Hildyard, C, Eyre, DW, Plaschkes, H, Griffith, J, Wolf, J, Fields, P, Gunawan, A, Oliver, R, Djebbari, F, Booth, S, McMillan, A, Fox, CP, Bishton, MJ, Collins, GP, Hatton, CSR

Immunogenicity of COVID ‐19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy by Lim, YJ, Ward, V, Brown, A, Phillips, E, Kronsteiner, B, Malone, T, Jennings, D, Healy, S, Longet, S, James, T, Thomson, P, Farrell, L, Oates, M, Jackson, R, Morrison, A, Burns, M, Carroll, M, Klenerman, P, Turtle, L, Naisbitt, D, Rhodes, M, Robinson, K, Gatto, S, Young, M, Eyre, TA, Eyre, DW, Dunachie, S, Barnes, E